Jump to site navigation [j]

383: Labelled Substance - Biodistribution

The overall aim of the work supported by this project licence is the development and provision of safe and effective medical diagnostic agents for the diagnosis, staging, monitoring and/or treatment of various disease states in man, such as cancer, chronic heart failure, Alzheimer’s disease, liver fibrosis and atherosclerosis.

Date: Tue Aug 29 14:18:16 BST 2006

Full Document

back to top

Home Office websites